Firstly, we used hepatocytes isolated from the livers of ZDF rats and Lepr-KO rats (but not from liver-specific Lepr-KO rats) to detect hepatic Lepr defective’s effect on metformin-treated NAFLD. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.